RePub, Erasmus University Repository

Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx Article

International Journal of Radiation: Oncology - Biology - Physics, 52(3), 755-768.

P.C. Levendag (Peter), F.J. Lagerwaard (Frank), I. Noever (Inge), C. DePan (Connie), A. VanNimwegen (Arent), O.B. Wijers (Oda), P.I.M. Schmitz (Paul), E.B. van Dieren (Erik) and P.J.C.M. Nowak (Peter)

March 2002
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: Urinary excretion predicts hematologic toxicity Article

Journal of Clinical Oncology, 20(5), 1222-1231.

D.F.S. Kehrer (Diederik), A.M. Bos (Annelies), J. Verweij (Jaap), H.J.M. Groen (Henk), W.J. Loos (Walter), A. Sparreboom (Alex), M.J.A. de Jonge (Maja), M. Hamilton, T. Cameron (Terri) and E.G.E. de Vries (Elisabeth)

March 2002
Testing Inference to the Best Explanation Article

Synthese, 130(3), 355-377.

I. Douven (Igor)

March 2002
Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34+ cells Article

Blood, 99(5), 1620-1626.

T. Kerre (Tessa), G. de Smet (Greet), M. de Smedt (Magda), A. Zippelius (Alfred), D. Pittet, A.W. Langerak (Anton), J. de Bosscher (José), F. Offner (Fritz), B. Vandekerckhove (Bart) and J. Plum (Jean)

March 2002
Launch decisions and competitive reactions: An exploratory market signaling study Article

Journal of Product Innovation Management, 19(3), 199-212.

E.J. Hultink (Erik Jan) and F. Langerak (Fred)

March 2002
Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes Article

Diabetes Care, 25(3), 458-463.

W.K. Redekop (Ken), M.A. Koopmanschap (Marc), R.P. Stolk (Ronald), G.E.H.M. Rutten (Guy), B.H.R. Wolffenbuttel (Bruce) and L.W. Niessen (Louis Wilhelmus)

March 2002
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal Review

D. Danso-Appiah (Anthony) and S.J. de Vlas (Sake)

March 2002
The MUC family: An obituary Review

J. Dekker (Jan), J.W. Rossen (John), H.A. Büller (Hans) and A.W.C. Einerhand (Sandra)

March 2002

Publication

Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx Article

Phase I and pharmacologic study of liposomal lurtotecan, NX 211: Urinary excretion predicts hematologic toxicity Article

Testing Inference to the Best Explanation Article

Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34+ cells Article

Launch decisions and competitive reactions: An exploratory market signaling study Article

Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes Article

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal Review

The MUC family: An obituary Review

About

Publication

Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx Article

Phase I and pharmacologic study of liposomal lurtotecan, NX 211: Urinary excretion predicts hematologic toxicity Article

Testing Inference to the Best Explanation Article

Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34+ cells Article

Launch decisions and competitive reactions: An exploratory market signaling study Article

Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes Article

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal Review

The MUC family: An obituary Review

Workflow

Workflow

Add Content